Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
Abstract Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels in malignant tumours. uPAR is closely related to the invasion and metastasis of malignant tumours, plays impo...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Revisão |
Language: | English |
Published: |
2022
|
Online Access: | https://doi.org/10.1186/s12967-022-03329-3 https://translational-medicine.biomedcentral.com/track/pdf/10.1186/s12967-022-03329-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|